Behind the Scenes of Eli Lilly's Latest Options Trends

Dec 17, 2024 · The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Eli Lilly, situated within the strike price …

CouponFollow Extension

$400
OFF

Behind The Scenes Of Eli Lilly's Latest Options Trends

2 weeks from now

Nov 29, 2024 · Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale trades within a strike price range from $400.0 to …

benzinga.com

$330
OFF

Eli Lilly's Options: A Look At What The Big Money Is Thinking

2 weeks from now

Jan 7, 2025 · Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale trades within a strike price range from $330.0 to …

benzinga.com

$240
OFF

Unpacking The Latest Options Trading Trends In Eli Lilly

2 weeks from now

Sep 12, 2024 · Below, we present a snapshot of the trends in volume and open interest for calls and puts across Eli Lilly's significant trades, within a strike price range of $240.0 to $1180.0, …

nasdaq.com

71%
OFF

A Closer Look At Eli Lilly's Options Market Dynamics

2 weeks from now

1 day ago · Present Market Standing of Eli Lilly Trading volume stands at 4,662,591, with LLY's price up by 3.71%, positioned at $873.4. RSI indicators show the stock to be may be …

nasdaq.com

10%
OFF

Eli Lilly Q4: Don't Miss Out On 2025 Gains, There's Limited Space Left

2 weeks from now

1 day ago · Since my first analysis of Eli Lilly (NYSE:LLY)(NEOE:LLY:CA) in early January 2025 where I issued a Strong Buy rating, the stock has gained 10% in price.So far, it appears that …

seekingalpha.com

$250
OFF

Eli Lilly's Options: A Look At What The Big Money Is Thinking

2 weeks from now

Jan 16, 2025 · Volume & Open Interest Trends. ... for all of Eli Lilly's whale trades within a strike price range from $250.0 to $1440.0 in the last 30 days. ... Stay informed about the latest Eli …

benzinga.com

45%
OFF

Lilly’s Mounjaro And Zepbound Contribute To Big Revenue Boost ...

2 weeks from now

1 day ago · Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 …

marketwatch.com

$500
OFF

Decoding Eli Lilly's Options Activity: What's The Big Picture?

2 weeks from now

Oct 23, 2024 · Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale trades within a strike price range from $500.0 to …

nasdaq.com

3%
OFF

Eli Lilly Up 13.3% In 2025: Stock Soars As New Breakthroughs Set …

2 weeks from now

1 day ago · In Q4, Eli Lilly posted a 45% jump in revenue to $13.53 billion, driven by the success of its diabetes and weight-loss treatments. Adjusted profit also beat expectations, coming in at …

yahoo.com

18%
OFF

Spotlight On Eli Lilly And Co: Analyzing The Surge In Options

2 weeks from now

Jun 17, 2024 · Eli Lilly and Co's Current Market Status Currently trading with a volume of 65,069, the LLY's price is down by -0.18%, now at $876.87. RSI readings suggest the stock is …

nasdaq.com

FAQs about Behind the Scenes of Eli Lilly's Latest Options Trends Coupon?

What is Eli Lilly known for?

Biggest Options Spotted: About Eli Lilly and Co Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. ...

What will Eli Lilly do in the future?

Eli Lilly is also developing new cancer therapies; by focusing on precision medicine, the company intends to improve survival rates. Perhaps most exciting for the company's long-term future is that it has partnered with OpenAI to harness AI for drug discovery. ...

What's a good price band for Eli Lilly & Co?

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $430.0 and $1000.0 for Eli Lilly and Co, spanning the last three months. Insights into Volume & Open Interest Looking at the volume and open interest is a powerful move while trading options. ...

Should you buy Eli Lilly & Co (ell)?

Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on Eli Lilly and Co with a target price of $957. An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $885. Options trading presents higher risks and potential rewards. ...

What makes Eli Lilly so successful?

Eli Lilly’s momentum stems from blockbuster GLP-1 therapies (Mounjaro, Zepbound), fuelling revenue growth, long-term margin expansion, and an ethos driving America’s health focus across obesity and beyond. ...

Is Eli Lilly a good investment?

Eli Lilly is not only a great investment, it is a company at the forefront of catalyzing making America healthy again. Mounjaro and Zepbound (the company's blockbuster weight-loss drugs) are lowering the risk of heart disease, stroke, and hypertension, while making people slimmer and improving their confidence regarding how they look. ...